Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Connie Chao Shern"'
Autor:
David Hunter, Peter Sharpe, Louise J Robertson, Julie S Moore, Kevin Blighe, Kok Yew Ng, Nigel Quinn, Fergal Jennings, Gary Warnock, Mark Clarke, Kathryn Maguire, Sharon Rainey, Ruth K Price, William P Burns, Amanda M Kowalczyk, Agnes Awuah, Sara E McNamee, Gayle E Wallace, Steve Sager, Connie Chao Shern, M Andrew Nesbit, James A D McLaughlin, Tara Moore
Publikováno v:
BMJ Open, Vol 11, Iss 6 (2021)
Objective To evaluate the dynamics and longevity of the humoral immune response to SARS-CoV-2 infection and assess the performance of professional use of the UK-RTC AbC-19 Rapid Test lateral flow immunoassay (LFIA) for the target condition of SARS-Co
Externí odkaz:
https://doaj.org/article/b61885bf745747f4952d53045ee0aca1
Autor:
Andrea Cusumano, Hila Roshanravan, Connie Chao-Shern, Jacopo Sebastiani, Jung Hee Levialdi Ghiron, Larry DeDionisio, Tara Moore
Publikováno v:
Journal of Medical Case Reports, Vol 16, Iss 1, Pp 1-8 (2022)
Abstract Background Inadequate response to corneal laser refractive surgery, e.g., ectatic corneal diseases, may not be identified by conventional examinations, hence creating therapeutic uncertainty. Herein we demonstrate the application of genetic
Externí odkaz:
https://doaj.org/article/369ca555efa64983bc2ad4f7b103609a
Autor:
John Blume, Ghristine Bundalian, Jessica Chan, Connie Chao-Shern, Jinlyung Choi, Rea Cuaresma, Kevin Dai, Sara N. Golmaei, Jun Heok Jang, Manoj Khadka, Ehdieh Khaledian, Thidar Khin, Yuya Kodama, Ajinkya Kokate, Joon-Yong Lee, Manway Liu, Hoda Malekpour, Megan Mora, Nithya Mudaliar, Preethi Prasad, Madhuvanthi Ramaiah, Saividya Ramaswamy, Peter Spiro, Kavya Swaminathan, Dijana Vitko, James Yee, Brian Young, Susan Zhang, Chinmay Belthangady, Bruce Wilcox, Brian Koh, Philip Ma
Publikováno v:
Cancer Research. 83:6597-6597
Pancreatic ductal adenocarcinoma (PDAC) is currently the 3rd leading cause of cancer-related deaths in the US. Although the all-stage 5-year survival rate is ~10%, early-stage 5-year survival is markedly superior and in excess of 40%. Hence, early de
Publikováno v:
Canadian Journal of Ophthalmology. 54:e308-e311
Autor:
Ehdieh Khaledian, Preethi Prasad, John Blume, Ghristine Bundalian, Connie Chao-Shern, Jinlyung Choi, Rea Cuaresma, Jared Deyarmin, Jun Heok Jang, Manoj Khadka, Thidar Khin, Yuya Kodama, Ajinkya Kokate, Joon-Yong Lee, Manway Liu, Nithya Mudaliar, Madhuvanthi Ramaiah, Saividya Ramaswamy, Peter Spiro, Kavya Swaminathan, Preston Williams, Mi Yang, James Yee, Brian Young, Robert Zawada, Susan Zhang, Chinmay Belthangady, Bruce Wilcox, Philip Ma
Publikováno v:
Cancer Research. 82:A038-A038
Pancreatic cancer is the third leading cause of cancer-related deaths in the United States. Disease biomarkers quantified from blood-based assays may help reduce mortality by enabling early detection, treatment selection, or response and resistance a
Autor:
Fergal Jennings, Agnes Awuah, Julie S Moore, Sara E. McNamee, James McLaughlin, David Hunter, R. K. Price, Nigel Quinn, Gayle E Wallace, Kathryn Maguire, William Burns, Kok Yew Ng, Connie Chao Shern, Sharon Rainey, Louise J. Robertson, Peter Sharpe, Kevin Blighe, Gary Warnock, Steve Sager, Amanda M. Kowalczyk, Mark Clarke, Tara Moore, M. Andrew Nesbit
Publikováno v:
BMJ Open, Vol 11, Iss 6 (2021)
BMJ Open
BMJ Open
ObjectiveTo evaluate the dynamics and longevity of the humoral immune response to SARS-CoV-2 infection and assess the performance of professional use of the UK-RTC AbC-19 Rapid Test lateral flow immunoassay (LFIA) for the target condition of SARS-CoV
Autor:
Kathleen A. Christie, Vance Thompson, Lawrence A. DeDionisio, M. Andrew Nesbit, C. B. Tara McMullen, Connie Chao-Shern, Jun-Heok Jang, Clara C. Chan
Publikováno v:
Eye
To date, 70 different TGFBI mutations that cause epithelial-stromal corneal dystrophies have been described. At present one commercially available test examines for the five most common of these mutations: R124H, R124C, R124L, R555W, and R555Q. To ex
Autor:
David Hunter, Louise J. Robertson, James McLaughlin, Quinn N, Maguire K, Clarke M, MA Nesbit, R. K. Price, William Burns, Kok Yew Ng, Warnock G, PC Sharpe, Agnes Awuah, Kevin Blighe, Amanda M. Kowalczyk, Johnny Moore, Sara E. McNamee, Jennings F, Tara Moore, G. D. Wallace, Segar S, Rainey S, Connie Chao Shern
Background The SARS-CoV-2 pandemic necessitated rapid and global responses across all areas of healthcare, including an unprecedented interest in serological immunoassays to detect antibodies to the virus. The dynamics of the immune response to SARS-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b826ae02e462ac37edc676bfece3f1ef
https://doi.org/10.1101/2020.09.29.20201509
https://doi.org/10.1101/2020.09.29.20201509
Autor:
Jesper Hjortdal, Jan J. Enghild, Emilie Hage Mogensen, Christian E. Weberskov, Nadia Sukusu Nielsen, Leif Schauser, Connie Chao Shern, Larry DeDionisio, Marie V. Lukassen, Tara Moore, Daniel E. Otzen, Ebbe Toftgaard Poulsen
Publikováno v:
Nielsen, N S, Poulsen, E T, Lukassen, M V, Chao Shern, C, Mogensen, E H, Weberskov, C E, DeDionisio, L, Schauser, L, Moore, T C B, Otzen, D E, Hjortdal, J & Enghild, J J 2020, ' Biochemical mechanisms of aggregation in TGFBI-linked corneal dystrophies ', Progress in Retinal and Eye Research, vol. 77, 100843 . https://doi.org/10.1016/j.preteyeres.2020.100843
Transforming growth factor-β-induced protein (TGFBIp), an extracellular matrix protein, is the second most abundant protein in the corneal stroma. In this review, we summarize the current knowledge concerning the expression, molecular structure, bin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90a2fd739da5eb26bc6495d3870af25c
https://pure.au.dk/portal/da/publications/biochemical-mechanisms-of-aggregation-in-tgfbilinked-corneal-dystrophies(576a837b-eb14-4f60-ae13-c5820163b8a8).html
https://pure.au.dk/portal/da/publications/biochemical-mechanisms-of-aggregation-in-tgfbilinked-corneal-dystrophies(576a837b-eb14-4f60-ae13-c5820163b8a8).html
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2145
CRISPR/Cas9 gene editing holds the promise of sequence-specific alteration of the genome to achieve therapeutic benefit in the treated tissue. Cas9 is an RNA-guided nuclease in which the sequence of the RNA can be altered to match the desired target.